On veut... VOYAGER SANS JET LAG
Food supplement declared in France, declaration No 2019-6-103
On veut... VOYAGER SANS JET LAG, from OH MY CREAM, is a food supplement declared in France. Status: withdrawn from the market on 26 November 2025. Main ingredients: Rosa centifolia 150 mg per day, Medicago sativa 134.4 mg per day, Auxenochlorella pyrenoidosa 21 mg per day, Oryza sativa 12.6 mg per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- not provided
- Food business operator placing the product on the market
- OH MY CREAM
- Status
- Withdrawn from the market on 26 November 2025
- Form
- Capsule
- Daily dose
- 3
- Directions for use
- avaler 1 à 3 gélules le soir au moment du coucher avec un grand verre d'eau
- Intended populations
- Men, Women
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, History of breast cancer, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Taking medication
- Objectives stated by the manufacturer (these are not authorised claims)
- Sleep
Declaration 295821, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Rosa centifolia L. | Pétales | Poudre (de plantes séchées ou broyées) | 150 mg |
| Medicago sativa L. | Parties aériennes | Extrait sec aqueux | 134.4 mg |
| Auxenochlorella pyrenoidosa (H.Chick) Molinari & Calvo-Pérez | Plante entière | Extrait sec aqueux | 21 mg |
| Oryza sativa L. | Graine | Extrait sec aqueux | 12.6 mg |
Additives
E414, E464, E470b
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
L'usage est déconseillé aux femmes enceintes et allaitantes, aux femmes ayant des antécédents personnels ou familiaux de cancer du sein, aux enfants et adolescents, aux personnes souffrant de maladies inflammatoires, auto-immunes et aux personnes devant réaliser une activité nécessitant une vigilance soutenue chez lesquelles une somnolence pourrait poser un problème de sécurité. Il est recommandé pour les personnes épileptiques, asthmatiques, souffrant de troubles de l'humeur, du comportement ou de la personnalité, ou suivant un traitement médicamenteux, de consulter leur médecin. Il est également recommandé de ne pas associer d'autres compléments alimentaires.
Regulatory points
- Conditions légales
Medicago sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Withdrawn from the market on 26 November 2025, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Medicago sativa L.
Read the warning, when it applies and the studies cited
ALFALFA - MEDICAGO SATIVA
Route of administration: Oral
Cautions and warnings
Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners, birth control medication or hormone therapy (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.
Contraindications
Condition of application: All products.
Do not use if you are pregnant or breastfeeding (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.
Applies to products providing more than 900 mg of Alfalfa dried herb top/leaf, per day.
Do not use if you have a history of systemic lupus erythematosus (Brinker 2010; Barnes et al. 2007; Boon and Smith 2004).
Sources cited by Health Canada (3)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines, 3rd edition. London (UK): Pharmaceutical Press; 2007.
- Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
- Brinker F. Herb Contraindications and Drug Interactions, 4e édition. Sandy (OR): Eclectic Medical Publications; 2010.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “On veut... VOYAGER SANS JET LAG: composition and regulation”, https://compoatlas.com/en/supplements/products/295821-on-veut-voyager-sans-jet-lag, updated 15 November 2026.